Work

Monoclonal gammopathy of undetermined significance: A primary care guide

Year: 2019

Type: article

Abstract: Monoclonal gammopathy of undetermined significance (MGUS) is commonly diagnosed in outpatients being worked up for an array of clinical concerns. It carries a risk of progression to myeloma and other lymphoproliferative disorders that, albeit low (1% per year), warrants regular follow-up. Patients with MGUS can be risk-stratified on the basis of the amount and type of their monoclonal protein as well as whether they have an abnormal light-chain ratio. Here, we provide a guide to the diagnosis, workup, and management of MGUS.

Source: Cleveland Clinic Journal of Medicine

DOI: 10.3949/ccjm.86a.17133

Authors: Jack Khouri, Christy Samaras, Jason Valent, Alex Mejia Garcia, Beth Faiman, Saveta Mathur, Kim Hamilton, Megan Nakashima, Matt Kalaycio

Institutions: Cleveland Clinic, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2909491281

FWCI: 1.602

Cites: 31

Cited by: 16

Related to: 10